In our study, we confirmed that administration of CLE decreased mucus hypersecretion in a mouse model of COPD, and decreased the mRNA levels of MUC5AC, MUC5B and MUC5AC protein production in in vitro experiments. Here, MUC5B is linked to chronic obstructive pulmonary disease.